Physician

Mohamed M Salem, M.D.

According to 2025 Medicare claims, Mohamed Salem, M.D. (NPI: 1861563215) practices internal medicine in the Wilmington, DE-MD-NJ market, with the plurality of this provider's patient population coming from Salem, NJ. This provider's primary affiliated billing organization is SALEM INTERNAL MEDICINE P.C. (NPI: 1437219730; TIN: 223623406) and primary practice location at 08069-3409.

Salem's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 338 traditional Medicare patients, billed 1,632 HCPCS/CPT codes, and received $106,425 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 8,831 prescription claims across 501 beneficiaries totaling $838,706 in drug costs, led by Ozempic (Semaglutide). DME data shows 215 claims. Open Payments data shows 20 records totaling $651. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $196,055 to $106,425. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $22,594 and ending at $15,931.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	681	3,504	$196,055
2016	629	3,474	$191,148
2017	699	3,797	$224,725
2018	664	3,803	$253,900
2019	533	2,564	$180,721
2020	521	2,945	$159,290
2021	463	2,814	$179,909
2022	416	1,909	$123,285
2023	378	1,678	$111,721
2024	338	1,632	$106,425

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	650	13,485	$1,141,532
2016	629	13,651	$988,516
2017	672	13,624	$1,003,644
2018	668	13,344	$1,069,342
2019	651	13,272	$1,096,673
2020	653	12,798	$1,041,468
2021	592	11,316	$1,096,554
2022	562	10,406	$1,123,794
2023	538	9,644	$1,074,338
2024	501	8,831	$838,706

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	186	742	$21,902
2016	175	654	$21,159
2017	175	703	$20,440
2018	111	501	$12,807
2019	95	549	$12,566
2020	82	453	$13,476
2021	59	233	$9,362
2022	47	240	$15,157
2023	43	228	$12,791
2024	39	215	$13,363

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	197	197	$128
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	30	31	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	220	346	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	294	773	$47
G0008	Administration of influenza virus vaccine	17	19	$29

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	65	3,808	$117,949
Eliquis	Apixaban	66	4,694	$92,710
Jardiance	Empagliflozin	33	2,910	$51,453
Januvia	Sitagliptin Phosphate	38	2,123	$35,993
Tradjenta	Linagliptin	42	1,520	$25,049

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	14	$8,511
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	31	$1,987
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	25	69	$989
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	14	$649
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	N/R	17	$600

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$651	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohamed M. Salem, M.D.?

Tedicare shows public-source Medicare data for Mohamed M. Salem, M.D. (NPI 1861563215), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohamed M. Salem, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mohamed M. Salem, M.D.?

Mohamed M. Salem, M.D. is linked to SALEM INTERNAL MEDICINE P.C. (billing NPI 1437219730) in the available physician profile data.

Does Mohamed M. Salem, M.D. have Open Payments data?

Mohamed M. Salem, M.D. has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.